Analytical Data
-
Gene name
IGSF21
- Application
-
Alternative Names
IGSF21Immunoglobulin superfamily member 21; IgSF21
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96ID5
-
Expression Region
1-467aa
-
AA Sequence
MRTAPSLRRCVCLLLAAILDLARGYLTVNIEPLPPVVAGDAVTLKCNFKTDGRMREIVWYRVTDGGTIKQKIFTFDAMFSTNYSHMENYRKREDLVYQSTVRLPEVRISDNGPYECHVGIYDRATREKVVLASGNIFLNVMAPPTSIEVVAADTPAPFSRYQAQNFTLVCIVSGGKPAPMVYFKRDGEPIDAVPLSEPPAASSGPLQDSRPFRSLLHRDLDDTKMQKSLSLLDAENRGGRPYTERPSRGLTPDPNILLQPTTENIPETVVSREFPRWVHSAEPTYFLRHSRTPSSDGTVEVRALLTWTLNPQIDNEALFSCEVKHPALSMPMQAEVTLVAPKGPKIVMTPSRARVGDTVRILVHGFQNEVFPEPMFTWTRVGSRLLDGSAEFDGKELVLERVPAELNGSMYRCTAQNPLGSTDTHTRLIVFENPNIPRGTEDSNGSIGPTGARLTLVLALTVILELT
-
Molecular Weight
78.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGSF21 (Immunoglobulin Superfamily Member 21) is a protein that plays a crucial role in various cellular processes, including immune regulation and signal transduction. As an important component of the immunoglobulin superfamily, its structural characteristics suggest potential involvement in cell-cell interactions and immune response modulation. Recent research has highlighted IGSF21's potential role in autoimmune diseases and cancer, making it a compelling target for therapeutic intervention. Studies have shown that IGSF21 can influence the activity of immune cells and modulate inflammatory responses, which is particularly relevant in the context of diseases characterized by dysregulated immune function. The production of recombinant IGSF21 protein enables researchers to explore its biological functions and interactions more thoroughly, facilitating a deeper understanding of its mechanisms. Additionally, this research could pave the way for the development of novel treatments aimed at manipulating IGSF21 pathways to restore immune balance in pathological conditions. Given the increasing prevalence of immune-related disorders, gaining insights into IGSF21 represents a promising avenue for biomedical research and therapeutic innovation.
